Baromètre Santé Adulte 2021-2022

NCT ID: NCT05218304

Last Updated: 2022-02-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

SUSPENDED

Clinical Phase

NA

Total Enrollment

5471 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-07-26

Study Completion Date

2022-05-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In 2021-2022, Agence Sanitaire et Sociale Nouvelle Calédonie (ASSNC) is undertaking the "Baromètre Santé Adulte" for the third time. This study is carried out this year in collaboration with WHO and Institut Pasteur de Nouvelle Calédonie (IPNC).

The main objective of this investigation is to describe the current levels of chronic disease risk factors in the adult population of New Caledonia aged from 18 to 64 years old. This study will also help to estimate prevalence of certain diseases (diabetes, hypercholesterolemia, renal failure), seroprevalence of arboviruses (dengue fever, Zika, chikungunya and Ross River) malaria as well as the seroprevalence of SARS-CoV-2.

Repeated regularly, these surveys allow the ASS-NC to capitalize on population indicators, to compare them according to socio-demographic characteristics, to identify groups at risk, to provide changes in health behaviors and to strengthen analytical capacities in order to adapt the guidelines for public policies and prevention programs.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The "Barometre Santé Adulte" is an observational, descriptive and cross-sectional study whose data collection will take place in New Caledonia.

For this study the sampling is based on the 2019 population census, according to a 3-stage stratified sample design. In total, the main sample will consist of approximately 5,500 people (first phase) and the sub-sample will consist of 1,800 people (second phase).

The participation rate is estimated at 60%. Data collection will take place from February to May at the people's place drawn according to two steps:

* Firstly, investigators will carry out a questionnaire with the people who gave their informed consent as well as taking physical measurements: height, weight, abdominal circumference and blood pressure. In addition to the socio-demographic characteristics of the respondents, the questionnaire deals with several health topics: consumption of psychoactive substances, diet, physical activity, health status and access to care, screening, oral health, driving motor vehicle risk, sexual health, mental health, etc. The time taken to complete the questionnaire is estimated at one hour.
* Secondly, and for a sub-sample of 1,800 people, nurses will come back to the people's places who volunteer to take a venous blood test: blood sugar, total cholesterol, HbA1c, serum creatinine, CBC and serology of diseases transmitted by mosquitoes (dengue, chikungunya, Zika and Ross River, malaria).

All the data collected will be entered on a tablet in the eSTEPS application. The analysis of data (R Studio software) and the drafting of the report will be carried out by ASSNC staff. The first results are expected for the second half of 2022.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Hypercholesterolemia Renal Failure Dengue Fever Zika Chikungunya Ross River Malaria SARS-CoV Infection Chronic Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

This is an observational, descriptive and cross-sectional study
Primary Study Purpose

OTHER

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Sample

questionnaires physical measurements (height, weight, perimeter abdominal and blood pressure)

Group Type NO_INTERVENTION

No interventions assigned to this group

Sub-sample - blood test

questionnaires physical measurements (height, weight, perimeter abdominal and blood pressure) Blood samples

Group Type EXPERIMENTAL

Blood sample

Intervention Type BIOLOGICAL

A questionnaire, physical measurements (height, weight, perimeter abdominal and blood pressure) for all arm will be done, approximately 5400 people carried out by investigators. Only 1800 will undergo blood samples carried out by nurses

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Blood sample

A questionnaire, physical measurements (height, weight, perimeter abdominal and blood pressure) for all arm will be done, approximately 5400 people carried out by investigators. Only 1800 will undergo blood samples carried out by nurses

Intervention Type BIOLOGICAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Individuals informed of the conduct of the research and having given their written consent to participate in the study (questionnaire and taking physical measurements);
* Individuals between the ages of 18 and 64;
* Individuals residing in New Caledonia in so-called "ordinary" housing under their main residence at the last population census in 2019;

Exclusion Criteria

* Pregnant or breastfeeding women;
* Tourists and transients staying in New Caledonia for less than 6 months at the time of the investigation;
* People who are not intellectually fit to answer the questionnaire;
* Persons subject to guardianship, curatorship or any other legal incapacity;
* For the second phase of the study will be excluded people describing a febrile syndrome;
Minimum Eligible Age

18 Years

Maximum Eligible Age

64 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Institut Pasteur

INDUSTRY

Sponsor Role collaborator

Pacific Community

OTHER

Sponsor Role collaborator

World Health Organization

OTHER

Sponsor Role collaborator

Institut de la Statitique et des Etudes Economiques Nouvelle Calédonie

UNKNOWN

Sponsor Role collaborator

Agence Sanitaire et Sociale de Nouvelle Calédonie

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Agence Sanitaire et Sociale Nouvelle Calédonie

Noumea, , New Caledonia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

New Caledonia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2021-A01260-41

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The French E3N Prospective Cohort Study
NCT03285230 ACTIVE_NOT_RECRUITING
The Ebeltoft Health Promotion Project
NCT00145782 COMPLETED PHASE3
Healthspan Connect Programme of Research
NCT07209774 NOT_YET_RECRUITING
The Lake Nona Life Project
NCT02533804 RECRUITING